Your browser doesn't support javascript.
loading
Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.
Delierneux, C; Donis, N; Servais, L; Wéra, O; Lecut, C; Vandereyken, M; Musumeci, L; Rahmouni, S; Schneider, J; Eble, J A; Lancellotti, P; Oury, C.
Afiliación
  • Delierneux C; Laboratory of Thrombosis and Hemostasis and Valvular Heart Disease, GIGA-Cardiovascular Sciences, Department of Cardiology, University of Liège, CHU Sart-Tilman, Liège, Belgium.
  • Donis N; Laboratory of Thrombosis and Hemostasis and Valvular Heart Disease, GIGA-Cardiovascular Sciences, Department of Cardiology, University of Liège, CHU Sart-Tilman, Liège, Belgium.
  • Servais L; Laboratory of Thrombosis and Hemostasis and Valvular Heart Disease, GIGA-Cardiovascular Sciences, Department of Cardiology, University of Liège, CHU Sart-Tilman, Liège, Belgium.
  • Wéra O; Laboratory of Thrombosis and Hemostasis and Valvular Heart Disease, GIGA-Cardiovascular Sciences, Department of Cardiology, University of Liège, CHU Sart-Tilman, Liège, Belgium.
  • Lecut C; Department of Laboratory Hematology, CHU Sart-Tilman, Liège, Belgium.
  • Vandereyken M; Immunology and Infectious Diseases Unit, GIGA-Signal Transduction, University of Liège, Liège, Belgium.
  • Musumeci L; Laboratory of Thrombosis and Hemostasis and Valvular Heart Disease, GIGA-Cardiovascular Sciences, Department of Cardiology, University of Liège, CHU Sart-Tilman, Liège, Belgium.
  • Rahmouni S; Immunology and Infectious Diseases Unit, GIGA-Signal Transduction, University of Liège, Liège, Belgium.
  • Schneider J; Luxembourg Center for Systems Biomedicine, University of Luxembourg, Luxembourg City, Luxembourg.
  • Eble JA; Institute for Physiological Chemistry and Pathobiochemistry, University of Münster, Münster, Germany.
  • Lancellotti P; Laboratory of Thrombosis and Hemostasis and Valvular Heart Disease, GIGA-Cardiovascular Sciences, Department of Cardiology, University of Liège, CHU Sart-Tilman, Liège, Belgium.
  • Oury C; Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy.
J Thromb Haemost ; 15(5): 983-997, 2017 05.
Article en En | MEDLINE | ID: mdl-28296036
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plaquetas / Glicoproteínas de Membrana / Inhibidores de Agregación Plaquetaria / Activación Plaquetaria / Lectinas Tipo C / Oligonucleótidos Fosforotioatos / Receptores Purinérgicos P2Y12 / Antagonistas del Receptor Purinérgico P2Y / Anticuerpos Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Thromb Haemost Asunto de la revista: HEMATOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plaquetas / Glicoproteínas de Membrana / Inhibidores de Agregación Plaquetaria / Activación Plaquetaria / Lectinas Tipo C / Oligonucleótidos Fosforotioatos / Receptores Purinérgicos P2Y12 / Antagonistas del Receptor Purinérgico P2Y / Anticuerpos Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Thromb Haemost Asunto de la revista: HEMATOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido